Merck Life Science

Congratulations to Duy-Viet Vo from the University of Illinois Chicago for winning the 5th Compound Challenge! The challenge asked participants to design the best synthetic route for a target molecule and Duy-Viet Vo did just that! Want to enter the winner's circle yourself? Sign-up for the 6th Compound Challenge now at http://ms.spr.ly/6040WVv7i

🎈 Ever wondered why helium makes balloons float? At the Curiosity Cube, our mobile science lab, employee volunteers like G help answer the curious questions left by our student visitors! #SPARKCuriosity Interested in learning more about the Curiosity Cube? Visit: http://ms.spr.ly/6049WRSOh

It's looking a little spooky in our bioprinting labs 🎃 👻. Rather than carving our pumpkins, we're printing them layer by layer. Interested in learning more about 3D bioprinting? Visit: http://ms.spr.ly/6047WuPjh

Exciting news! We’re investing €70 million to triple our Antibody-Drug Conjugate (ADC) manufacturing capacity in St. Louis, Missouri. This expansion reinforces our commitment to advancing these cutting-edge novel therapies, and to our clients and ultimately patients. ADCs precisely target cancer cells, sparing healthy ones—one of the most promising advances in cancer treatment today. Together with our clients, we’re unlocking ADCs’ full potential to impact life and health with science. Learn more here: http://ms.spr.ly/6045W3d5U

The speed at which we can test a medicine’s safety and efficacy directly affects the progress of drug development. Hear from Melisa Wilson as she shares the story behind our new Blazar CHO Animal Origin Free panel and how it’s accelerating the delivery of life-changing medicines to patients with greater speed and safety.

Jeffrey Whitford has had a vision for over a decade, and more importantly, he’s turned that vision into impact—for Merck, our customers, and our planet. Overseeing our sustainability efforts across Merck Life Science, Jeffrey has built an industry-leading program from the ground up. Starting as a team of one, he has now integrated sustainability into every facet of our operations. All with quiet confidence and a vision for a better world. Under his stewardship, we’ve made our packaging more sustainable, provided customers with transparent and actionable sustainability data, reimagined product design to prioritize sustainability, and focused our sustainable operational efforts where they can have the greatest impact. Beyond sustainability, Jeffrey has launched science education programs, like the Curiosity Cube, that have collectively reached over 10 million students, preparing the next generation of innovators. For these reasons and many more, Jeffrey is the first-ever Merck Life Science CEO Award recipient given to an individual—there couldn't be a more fitting colleague. His entrepreneurial mindset and tireless commitment have positioned Merck Life Science as a sustainability leader. His vision has created a strong foundation, and I know he and the entire team are only just getting started. Congratulations, Jeffrey, and thank you to all the colleagues who have help drive our sustainability efforts every day.

Parkinson’s is one of the fastest-growing neurological disorders, affecting 10 million people today. Our collaboration with The Michael J. Fox Foundation for Parkinson's Research brings SMC immunoassay technology to the scientific community. This technology detects biomarker changes, enabling researchers to measure how different therapies impact disease progression and improve treatment approaches.

Our Molsheim, France site has gone PINK in October! Once again, our campus in Molsheim has been lit up in pink to bring awareness to breast cancer. Local employees also participate in fundraising events to support the fight against breast cancer. #BreastCancerAwareness

With over 300,000 products in our portfolio, we’ve learned a lot about scaling up a product from pilot batches to commercial manufacturing. Now, we leverage this expertise in our Contract Manufacturing Services to help customers scale their products for market. Learn more: http://ms.spr.ly/6041mfOg7

Join us on LinkedIn for a live and interactive panel discussion to explore the future of ADCs in cancer treatment. The discussion will focus on recent advancements in technology and integration with other therapies. Key topics will include innovations in antibody engineering, linker chemistry, payload selection, the role of biomarkers, and challenges in manufacturing. This event is an excellent opportunity for experts, researchers, clinicians, and industry professionals to gain insights into the latest developments and future directions of ADCs. Click Attend to RSVP.